MEDP
$599.47+0.23%
as of close, Oct 2, 2026
☾ AH $599.47 +0.23%
MEDP financial statements
The full income statement, balance sheet, and cash-flow statement for Medpace Holdings Inc. (MEDP), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 31.0M2024-09 31.1M2024-12 30.5M2025-03 28.7M2025-06 28.1M2025-09 28.2M2025-12 28.4M2026-03 28.6M2026-06 27.9M-10.0% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 2.53B+20.0% | 2.11B+11.8% | 1.89B+29.2% | 1.46B+27.8% | 1.14B+23.4% | |
| Selling, general & administrative | 198M+9.6% | 180M+11.7% | 161M+22.8% | 131M+21.2% | 108M+17.6% | |
| Amortization of intangibles | 946K-34.4% | 1.44M-34.4% | 2.20M-34.4% | 3.35M-34.5% | 5.11M-35.1% | |
| Provision for credit losses | 29.0K-74.3% | 113K-96.7% | 3.42M | 0.00-100.0% | 11.0K-93.4% | |
| Operating income | 535M+19.7% | 447M+32.7% | 337M+20.9% | 279M+40.3% | 199M+18.9% | |
| Other non-operating income | -5.34M-231.6% | 4.06M+719.2% | -655K-109.3% | 7.07M+111.5% | 3.34M+182.5% | |
| Pre-tax income | 542M+14.0% | 476M+41.8% | 336M+18.7% | 283M+40.1% | 202M+19.8% | |
| Income tax | 91.3M+27.6% | 71.5M+35.3% | 52.9M+41.0% | 37.5M+87.4% | 20.0M-13.6% | |
| 451M+11.6% | 404M+43.0% | 283M+15.3% | 245M+34.9% | 182M+25.1% | ||
| Net income to common | 451M+11.6% | 404M+43.1% | 283M+15.3% | 245M+35.2% | 181M+25.2% | |
| $15.28+21.0% | $12.63+42.2% | $8.88+22.0% | $7.28+51.4% | $4.81+25.3% | ||
| EPS (basic) | $15.64+19.8% | $13.06+42.0% | $9.20+21.5% | $7.57+49.6% | $5.06+24.3% | |
| Weighted-avg shares (basic) | 28.8M-6.8% | 31.0M+0.8% | 30.7M-5.1% | 32.4M-9.7% | 35.9M+0.6% | |
| Weighted-avg shares (diluted) | 29.5M-7.8% | 32.0M+0.5% | 31.8M-5.4% | 33.7M-10.7% | 37.7M-0.0% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 990M-3.8% | 1.03B+73.3% | 594M+77.8% | 334M-51.7% | 691M+45.9% | ||
| Cash & equivalents | 497M-25.8% | 669M+172.7% | 245M+768.4% | 28.3M-93.9% | 461M+66.1% | |
| Accounts receivable | 402M+35.6% | 296M-0.7% | 298M+17.8% | 253M+35.9% | 186M+15.8% | |
| Prepaid expenses | 90.5M+42.9% | 63.4M+26.8% | 50.0M-4.4% | 52.3M+21.1% | 43.2M+23.6% | |
| 1.98B-6.0% | 2.10B+26.8% | 1.66B+22.5% | 1.35B-18.5% | 1.66B+19.4% | ||
| Property, plant & equipment | 131M+6.0% | 124M+2.5% | 121M+9.8% | 110M+17.9% | 93.2M+9.6% | |
| Operating lease right-of-use | 118M-8.4% | 129M-11.2% | 145M+4.1% | 139M+7.3% | 130M+13.8% | |
| Goodwill | 662M+0.0% | 662M+0.0% | 662M+0.0% | 662M+0.0% | 662M+0.0% | |
| Intangible assets | 33.4M-2.8% | 34.4M-4.0% | 35.8M-5.8% | 38.0M-8.1% | 41.4M-11.0% | |
| Deferred tax assets | 19.2M-80.8% | 100M+34.8% | 74.4M+54.8% | 48.1M+91.3% | 25.1M+4589.2% | |
| Other non-current assets | 21.9M-1.4% | 22.3M-10.9% | 25.0M+18.2% | 21.1M+21.3% | 17.4M+98.1% | |
| 1.34B+21.7% | 1.10B+19.4% | 925M+15.1% | 803M+44.2% | 557M+26.6% | ||
| Accounts payable | 28.1M-13.5% | 32.5M+2.1% | 31.9M-3.6% | 33.1M+28.8% | 25.7M-3.3% | |
| Accrued liabilities | 408M+32.7% | 308M+5.1% | 293M+39.4% | 210M+31.9% | 159M+18.5% | |
| Deferred revenue | 854M+20.2% | 711M+26.9% | 560M+21.0% | 463M+34.3% | 345M+34.8% | |
| Short-term & current debt | — | — | 0.00-100.0% | 50.0M | 0.00 | |
| Current lease liability | 23.2M-0.3% | 23.3M+4.1% | 22.4M+16.0% | 19.3M+18.4% | 16.3M+2.4% | |
| Other current liabilities | 52.8M-1.5% | 53.6M+32.6% | 40.4M-14.9% | 47.5M+72.2% | 27.6M+17.4% | |
| 1.52B+18.9% | 1.28B+16.2% | 1.10B+13.6% | 966M+36.6% | 707M+20.9% | ||
| Non-current lease liability | 114M-10.0% | 126M-11.2% | 142M+2.3% | 139M+6.0% | 131M+13.7% | |
| Operating lease liability (total) | 137M-8.5% | 150M-9.1% | 164M+4.0% | 158M+7.4% | 147M+12.4% | |
| Deferred tax liabilities | 1.35M-24.7% | 1.80M-25.1% | 2.40M+124.7% | 1.07M-0.9% | 1.08M-92.0% | |
| Other non-current liabilities | 57.7M+34.9% | 42.7M+51.4% | 28.2M+24.3% | 22.7M+27.9% | 17.7M+10.3% | |
| 459M-44.4% | 826M+47.7% | 559M+44.7% | 386M-59.5% | 953M+18.3% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 284K-7.2% | 306K-0.6% | 308K-0.3% | 309K-14.2% | 360K+1.4% | |
| Additional paid-in capital | 936M+10.9% | 844M+5.2% | 803M+4.1% | 771M+5.9% | 728M+4.6% | |
| Retained earnings | -460M-5732.2% | 8.17M+103.7% | -222M+38.4% | -360M-253.1% | 235M+103.9% | |
| Treasury stock | 12.2M-0.6% | 12.2M-0.7% | 12.3M-1.4% | 12.5M+130.3% | 5.43M-2.7% | |
| Accumulated other comprehensive income | -4.91M+66.7% | -14.7M-46.4% | -10.1M+18.7% | -12.4M-155.7% | -4.85M-3599.2% | |
| Total liabilities & equity | 1.98B-6.0% | 2.10B+26.8% | 1.66B+22.5% | 1.35B-18.5% | 1.66B+19.4% | |
| Common shares issued | 28.4M-7.4% | 30.6M-0.4% | 30.8M-1.1% | 31.1M-13.7% | 36.0M+1.4% | |
| Common shares outstanding | 28.4M-7.4% | 30.6M-0.4% | 30.8M-1.1% | 31.1M-13.7% | 36.0M+1.4% | |
| Shares outstanding (cover) | 28.4M-6.8% | 30.5M-1.0% | 30.8M-0.9% | 31.1M-11.9% | 35.2M-1.4% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 713M+17.1% | 609M+40.5% | 433M+11.7% | 388M+47.4% | 263M+1.8% | ||
| Depreciation & amortization | 28.1M-3.9% | 29.3M+11.1% | 26.3M+17.8% | 22.3M+5.8% | 21.1M+8.1% | |
| Intangible amortization | 946K-34.4% | 1.44M-34.4% | 2.20M-34.4% | 3.35M-34.5% | 5.11M-35.1% | |
| Share-based compensation | 34.8M+36.3% | 25.5M+24.4% | 20.5M-4.2% | 21.4M+48.0% | 14.5M+5.0% | |
| Deferred income taxes | 80.9M+403.9% | -26.6M-6.6% | -25.0M-8.5% | -23.0M+38.0% | -37.1M-7142.1% | |
| Change in payables | 2.63M+188.7% | -2.96M-382.1% | 1.05M-83.7% | 6.43M+244.6% | 1.87M+171.9% | |
| -31.1M-10.0% | -28.3M+18.3% | -34.6M+10.6% | -38.7M-23.5% | -31.4M-0.5% | ||
| Capital expenditure | 31.4M-14.2% | 36.5M-0.3% | 36.6M-0.6% | 36.9M+30.4% | 28.3M-9.8% | |
| Free cash flow | 682M+19.2% | 572M+44.2% | 397M+13.0% | 351M+49.4% | 235M+3.4% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other investing activities | -216K+97.4% | -8.24M-308.1% | -2.02M-208.4% | 1.86M-39.8% | 3.09M+2554.8% | |
| -860M-458.7% | -154M+15.7% | -183M+76.5% | -776M-1645.2% | -44.5M+46.0% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 917M+440.1% | 170M+17.9% | 144M-83.0% | 848M+1265.4% | 62.1M-36.8% | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | 5.92M+335.7% | -2.51M-332.3% | 1.08M+116.4% | -6.57M-65.5% | -3.97M-696.4% | |
| Net change in cash | -172M-140.7% | 424M+95.2% | 217M+150.2% | -433M-335.9% | 184M+25.8% | |
| Interest paid | 0.00-100.0% | 171K-94.4% | 3.06M+4.1% | 2.94M+2286.2% | 123K+18.3% | |
| Income taxes paid | 39.7M-52.5% | 83.6M+9.4% | 76.4M+52.2% | 50.2M-10.8% | 56.2M+143.4% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 15.9B+57.5% | 10.1B+7.6% | 9.41B+42.4% | 6.61B-13.8% | 7.67B+54.1% | |
| P/E | 35.3×+41.2% | 25.0×-27.3% | 34.4×+18.2% | 29.1×-30.9% | 42.2×+23.2% | |
| P/S | 6.3×+31.3% | 4.8×-9.1% | 5.3×+9.8% | 4.8×-28.4% | 6.7×+24.9% | |
| P/B | 34.7×+183.2% | 12.3×-38.6% | 20.0×+5.8% | 18.9×+134.7% | 8.0×+30.3% | |
| P/FCF | 23.4×+32.2% | 17.7×-29.0% | 24.9×+7.6% | 23.1×-29.1% | 32.6×+49.1% | |
| Earnings yield | 2.8%-29.2% | 4.0%+37.5% | 2.9%-15.4% | 3.4%+44.7% | 2.4%-18.9% | |
| FCF yield | 4.3%-24.3% | 5.7%+40.8% | 4.0%-7.1% | 4.3%+41.0% | 3.1%-32.9% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: MEDP’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MEDP filings on SEC EDGAR → Not investment advice.